Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections - Top-Institutions - MDSpire

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections

  • By

  • Jesenko Karačić

  • Miriam Grosse

  • Kenneth Pfarr

  • Andrea Schiefer

  • Tanja Schneider

  • Achim Hoerauf

  • Sabina Karačić

  • Marijo Parčina

  • Gunnar Hischebeth

  • Frank Sebastian Fröschen

  • Gabriele Bierbaum

  • March 12, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Microbiology
    • Antimicrobial Drug Development

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Microbiology
    • Pharmacology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Microbial Pathogenesis
    • Pharmaceutical Sciences

  • #4

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Infectious Diseases
    • Microbiology
    • Antimicrobial Drug Discovery

  • #5

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases Research
    • Antimicrobial Resistance
    • Drug Development

Original Source(s)

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections

  • by Jesenko Karačić, Miriam Grosse, Kenneth Pfarr, Andrea Schiefer, Tanja Schneider, Achim Hoerauf, Sabina Karačić, Marijo Parčina, Gunnar Hischebeth, Frank Sebastian Fröschen, Gabriele Bierbaum

  • March 12, 2026

Related Content

Alopecia Associated with Isoniazid in Cases of Isoniazid-Monoresistant Pulmonary Tuberculosis

Analysis of infection characteristics and clinical predictive indicators of different bacterial diabetic foot in Yunnan area

Is “Against Medical Advice” Still Defensible?

A Viewpoint calls for more dignifying, harm-reduction–oriented hospital discharges for patients with OUD.